Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.75
-0.22 (-3.16%)
At close: Apr 24, 2026, 4:00 PM EDT
6.75
0.00 (0.00%)
After-hours: Apr 24, 2026, 4:00 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $179.47 million as of April 24, 2026. Its market cap has decreased by -27.23% in one year.
Market Cap
179.47M
Enterprise Value
73.10M
1-Year Change
-27.23%
Ranking
Category
Stock Price
$6.75
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $179.47M, an increase of 8.07%. That is a compound annual growth rate of 3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 184.77M | -1.45% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 201.06M |
| Precision BioSciences | 200.75M |
| Heron Therapeutics | 196.08M |
| Black Diamond Therapeutics | 193.06M |
| Unicycive Therapeutics | 192.06M |
| Tonix Pharmaceuticals Holding | 187.01M |
| Corbus Pharmaceuticals Holdings | 186.76M |
| ProQR Therapeutics | 183.86M |